| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10037354 | HBV | ENSG00000080644.16 | protein_coding | CHRNA3 | No | No | 1136 | P32297 |
| TVIS10032120 | HBV | ENSG00000080644.16 | protein_coding | CHRNA3 | No | No | 1136 | P32297 |
| TVIS10039140 | HBV | ENSG00000080644.16 | protein_coding | CHRNA3 | No | No | 1136 | P32297 |
| TVIS30039129 | HIV | ENSG00000080644.16 | protein_coding | CHRNA3 | No | No | 1136 | P32297 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CHRNA3 |
|---|---|
| DrugBank ID | DB01273 |
| Drug Name | Varenicline |
| Target ID | BE0003585 |
| UniProt ID | P32297 |
| Regulation Type | partial agonist |
| PubMed IDs | 16766716 |
| Citations | Mihalak KB, Carroll FI, Luetje CW: Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 2006 Sep;70(3):801-5. Epub 2006 Jun 9. |
| Groups | Approved; Investigational |
| Direct Classification | |
| SMILES | C1C2CNCC1C1=C2C=C2N=CC=NC2=C1 |
| Pathways | |
| PharmGKB | PA164781343 |
| ChEMBL | CHEMBL1396 |
